What's Hot
View all perspectives
David Liew drdavidliew
2 years 5 months ago
Nice session (joint chaired @AurelieRheumo) on AI in rheumatology - particularly from Michael Barnes on deciphering the polyome.
It's a whole door opened with insights beyond, but some careful steps necessary first (& cross-disciplinary footsteps to follow)
#EULAR2022 @RheumNow https://t.co/vLfDvcEnxo
Eric Dein ericdeinmd
2 years 5 months ago
#EULAR2022 RA Recommendations
⭐️Last update 2019
▶️GC use when starting csDMARD - but taper and STOPPED asap.
🔔This contrasts with ACR2021 rec to avoid GC
▶️JAKi no longer equal to bDMARDs, consider usage with risk assessment
@RheumNow https://t.co/fotMgdrFop
TheDaoIndex KDAO2011
2 years 5 months ago
What is the wait period for a patient to see a rheumatologist in your country?
Danish laws mandates the wait for a rheumatologist cannot be longer than 4 weeks (either by telemedicine or in person appts). #EULAR2022 @rheumnow https://t.co/TaYysIyGSi
Aurelie Najm AurelieRheumo
2 years 5 months ago
“Tomorrow’s challenge is not to accumulate data, it’s to store, platform, analyse and make the most of these data. It will need to be #digital and #human” @DanielAletaha during the #EULAR2022 opening ceremony @RheumNow
Aurelie Najm AurelieRheumo
2 years 5 months ago
Does AI really help to diagnose RMDs? Well this is the question we will try to answer today. We are waiting for you in Hall D5 for the AI session starting at 2.15pm ✨
@DiegoBenavent @eular_org #EULAR2022
@RheumNow https://t.co/JoKELQKMcE
Eric Dein ericdeinmd
2 years 5 months ago
#EULAR2022 ANCA associated recommendations:
Bactrim prophylaxis recommended for patients on RTX, CYC, and/or high dose glucocorticoids 💊
@RheumNow https://t.co/5JvcZpI5jq
TheDaoIndex KDAO2011
2 years 5 months ago
#EULAR2022 AAV Reccs Revised: Plasma exchange can be considered for pts with GPA/MPA in pts w/active GN (not for alveolar hemorrhage) @rheumnow https://t.co/zkJljHgly4
Dr. John Cush RheumNow
2 years 5 months ago
Where is overall mattock disease following a covid vaccine range from 4.4 to 14.9% period this study of 4627 showed an 11.7% flare rate within 3 months of VAX #EULAR2022 abtr POS 0200 https://t.co/sxI4791rll
Dr. John Cush RheumNow
2 years 5 months ago
Baricitinib fails in 2 phase 3 lupus trials, BRAVE I & II #EULAR2022 abtr POS 0190 https://t.co/ecGA2A42kP
Dr. John Cush RheumNow
2 years 5 months ago
Voclosporin in lupus nephritis - good 3 year continuation data. #EULAR2022 abtr POS 0186 https://t.co/s4Dj6ZTh71
Poster Hall